UPDATE 2-Biogen gets DOJ subpoena on business operations in foreign countries
(Adds Biogen response in paragraph 3)
Feb 14 (Reuters) - Biogen has received a subpoena from the U.S. Department of Justice seeking information relating to the company's business operations in several foreign countries, the drugmaker disclosed in a regulatory filing on Wednesday.
Biogen also said it is providing information on foreign business operations to the U.S. Securities and Exchange Commission.
When contacted by Reuters, the company did not disclose details on the subpoena and said it "does not comment on investigations".
The DOJ and the SEC did not immediately respond to Reuters' requests for comments.
Biogen, which reported fourth-quarter results on Tuesday, operates in markets including Japan and countries in Europe. It has manufacturing facilities in Switzerland and North Carolina in the United States. (Reporting by Sriparna Roy in Bengaluru; Editing by Shounak Dasgupta and Maju Samuel)
